SecBot SecBot
8-K ·Filed Oct 29, 2026

ESLA

Estrella Immunopharma, Inc.
NEUTRAL
Impact 3/10
Processed1h 20m ago SEC0001213900-26-113912
8-K context-dependent: Items 5.02, 8.01

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-113912
Document: ea0310209-8k_estrella.htm0001213900-26-113912
Document: ea031020901ex10-2.htm0001213900-26-113912
Document: ea031020901ex10-3.htm0001213900-26-113912
Document: 0001213900-26-113912-index-headers.html0001213900-26-113912
Document: 0001213900-26-113912-index.html0001213900-26-113912
Document: 0001213900-26-113912.txt0001213900-26-113912

US Market Status

Market Closed · Opens Fri (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 29, 2026

Fresh ESLA Intelligence

Analysis is for subscribers only.

Subscribe for Full Access